Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Textual 1)

v3.6.0.2
Stockholders' Equity (Details Textual 1)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2014
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Jun. 30, 2016
$ / shares
shares
Jun. 30, 2015
shares
Dec. 31, 2016
CAD / shares
Stockholders Equity Note [Line Items]                
Exercise price | $ / shares   $ 3.00 $ 0.004 $ 3.00 $ 0.004      
Issuance of cash | $       $ 582,511        
Gross proceeds of cash | $       1,903,514        
Increase value in additional paid in capital and accumulated deficit | $       $ 29,594        
Preferred stock, par value | $ / shares   0.001   $ 0.001   $ 0.001    
Common stock, par value | $ / shares   $ 0.001   $ 0.001   $ 0.001    
Common stock issued and outstanding exchanged basis | shares   1,014,011   1,014,011        
Stock option (income) expense | $       $ (43,384) $ 114,868      
Weighted average contractual term       3 years        
Proceeds from the exercise of warrants | $       $ 326,699 405,183      
Stock options [Member]                
Stockholders Equity Note [Line Items]                
Number of stock options outstanding | shares   896,250   896,250   856,250    
Recognized as stock option liability | $       $ 260,969        
Aggregate intrinsic value of stock options outstanding | $   $ 208,846 $ 530,269 208,846 530,269      
Aggregate intrinsic value of stock options exercisable | $   208,846 $ 515,424 208,846 $ 515,424      
Unrecognized compensation expense | $   $ 148,834   148,834        
Aggregate intrinsic value of unvested stock options | $       $ 85,094        
Amendment shares of stock option exercise price | shares   43,750   43,750        
Stock options [Member] | 1.49 [Member]                
Stockholders Equity Note [Line Items]                
Exercise price | (per share)   $ 1.49   $ 1.49       CAD 2.00
Number of stock options outstanding | shares   25,000   25,000        
Series A Preferred Stock [Member]                
Stockholders Equity Note [Line Items]                
Preferred stock, shares issued | shares   278,530   278,530   278,530    
Preferred stock, par value | $ / shares   $ 1.00   $ 1.00   $ 1.00    
Series A Preferred Stock [Member] | Exchange Agreement                
Stockholders Equity Note [Line Items]                
Preferred stock, shares issued | shares 278,530              
Preferred stock, par value | $ / shares $ 1.00              
Preferred Stock, rate of dividend 3.00%              
Series B Preferred Stock [Member]                
Stockholders Equity Note [Line Items]                
Series B Preferred stock dividends, shares | shares   50,096 0 100,889 0      
Preferred stock, shares issued | shares   889,863   889,863   902,238    
Preferred Stock, rate of dividend           9.00%    
Description of dividend payment           Each share of Series B Preferred Stock is convertible into 2.5 shares of common stock equating to a conversion price of $3.20 (the "Conversion Price") and will automatically convert to common stock at the earlier of 24 hours following regulatory approval of VAL-083 with a minimum closing bid price of $8.00 or five years from the final closing dates. The holders of the Series B Preferred Stocks are entitled to an annual cumulative, in arrears dividend at the rate of 9% payable quarterly. The 9% dividend shall accrue quarterly commencing on the date of issue and be payable quarterly on June 30, September 30, December 31, and March 31 of each year commencing on June 30, 2016.    
Converted shares of common stock | shares   12,375 0 30,938 0      
Accumulated deficit [Member]                
Stockholders Equity Note [Line Items]                
Series B Preferred stock dividends | $   $ 159,756 $ 0 $ 467,054        
Investor Warrant Amendments [Member]                
Stockholders Equity Note [Line Items]                
Warrants expiration date           Mar. 31, 2017 Mar. 31, 2017  
Number of stock options outstanding | shares           181,156    
Number of warrants issued | shares           15,944 0  
2015 Investor Warrants [Member]                
Stockholders Equity Note [Line Items]                
Exercise price | $ / shares     $ 3.00   $ 3.00      
Warrants expiration date         Jul. 31, 2020      
Common stock, par value | $ / shares     2.40   $ 2.40      
Common stock shares issued on exercise of warrants | shares         1,069,417      
Issuance of shares and warrants - net of issue costs, shares | shares         1,069,417      
Proceeds from the exercise of warrants | $       $ 120,000 $ 2,566,660      
Term of warrants         5 years      
2015 Agent Warrants [Member]                
Stockholders Equity Note [Line Items]                
Sale of stock description         Under the Company's engagement agreements with these placement agents, the Company agreed to pay up to a 7% cash commission and issue warrants to purchase shares of common stock (the "2015 Agent Warrants") up to the number of shares of our common stock equal to 5% of the aggregate number of shares sold in the Offering by such placement agent.      
Total cash commission | $         $ 80,575      
Exercise price | $ / shares     $ 3.00   $ 3.00      
Warrants expiration date         Jul. 15, 2020      
Investor warrants, description       680 of the 2015 Agent Warrants were exercised for cash proceeds of $2,040 and 1,000 of the 2015 Agent Warrants were exercised on a cashless basis for 594 shares of common stock.        
Number of warrants issued | shares       1,000 23,477      
Proceeds from the exercise of warrants | $       $ 2,040